|
Home
Page
Bella Mira Essential Oil
Supplements
Organic Carrier Oils
Diffusers
Bella Mira Skin Care
Essential Oil Information and Use
Express Order Form
Essential Oil
Singles
Essential Oil
Blends
Essential Oil
Kits
Essential Oil Supplies
Gluten Free Living and Recipes
Thyroid 101
Fibromyalgia 101
PAIN Relief and Information
Detoxification and Digestion Products
Pet Place
Save Your Computer Free Protection
CD's DVD's and Books
3-D Screensavers
Hormone Balance Test New
Improved
Thyroid Function Test
Internal Toxicity Test

Gift Certificates
Link Exchange/Banners
.gif)

Our
Shopping Cart Is:

& FAQ



| |
Birth Control Patch Too Dangerous to Stay on
Market 10-15-08
by: David Gutierrez
Johnson & Johnson's Ortho-Evra
birth control patch exposes women to too much risk for too little benefit and
should be pulled from the market, the nonprofit group Public Citizen warned in a
petition submitted to the FDA.
"Ortho-Evra is a poor choice for women," wrote Dr. Sidney Wolfe, director of
Public Citizen's Health Research Group.
The Ortho-Evra patch is designed to be worn on the skin and changed once weekly,
in contrast to birth control pills, which are taken daily. When Johnson &
Johnson introduced the patch in 2001, it said that it would be preferable to a
pill because it would provide lower and more stable estrogen levels, and would
be easier for women to take. But studies have shown that the first two claims
are not true, and Public Citizen says that improved compliance is not enough of
a benefit to outweigh the serious risks that have emerged.
According to a review conducted by Public Citizen, the birth control patch
exposes women to up to 60 percent more estrogen than the pill, and a variation
in hormone levels anywhere from 1.2 to 3.5 times higher.
"Had Ortho-Evra been designed as a pill, it is unlikely to have been approved
because of its increased estrogen content," Wolfe said.
In 1988, the FDA banned birth-control pills containing more than 50 micrograms
of estrogen, due to the risk of fatal blood clots. Ortho-Evra exposes patients
to the equivalent of a 56 microgram pill or more.
Studies suggest that women using Ortho-Evra have twice the risk of blood clots
as women taking the pill, and are also at increased risk for other side effects
such as breast discomfort, nausea, vomiting and severe menstrual pain.
The FDA has updated the drug's label with warnings about blood clots three times
since 2005, and sales have dropped from 9.9 million prescriptions in 2004 to 2.7
million in 2007.
Public Citizen has asked the FDA to phase out sales of the drug over a six-month
period.
Comments:
Rhythm method and lambskin or non lubricated condoms are the healthiest
choices for married couples. Any hormone method has serious risks.
|